Royalty Pharma Overview
- Investor Type
-
Asset Manager
- Status
-
Active
- Professionals
-
13
- Investments
-
54
- Portfolio
-
12
- Exits
-
7
Royalty Pharma General Information
Company Description
Founded in 1996, Royalty Pharma is an asset manager based in New York. The firm seeks to invest in the biopharmaceuticals, life sciences, and pharmaceuticals sectors. The firm targets royalty interests in marketed therapies and late-stage development candidates, providing funding for clinical trials and product launches. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.royaltypharma.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 110 East 59th Street
- Floor 33
- New York, NY 10022
- United States
Royalty Pharma Investments & Acquisitions (54)
Royalty Pharma’s most recent investment was a with Cliramitug for . The deal was made on 22-Jul-2026 with as the lead partner.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cliramitug | 22-Jul-2026 | Buildings and Property | Generating Revenue | |||
| PTC Therapeutics (Certain Royalty Rights) | 30-Dec-2025 | Buildings and Property | ||||
| Royalty Pharma (Cancer Drug Royalties in United States) | 16-Dec-2025 | Buildings and Property | ||||
| Alnylam Pharmaceuticals (Royalties and Commercial Milestones for Inclisiran based in United States) | 02-Nov-2025 | Pharmaceuticals | ||||
| Kailera Therapeutics | 14-Oct-2025 | Early Stage VC | Drug Discovery | Generating Revenue |
Royalty Pharma Exits (7)
Royalty Pharma has made a total of 7 exits. Its latest exit was from Kailera Therapeutics for on 17-Apr-2026. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Kailera Therapeutics | 17-Apr-2026 | ||
| Elektrofi | 18-Nov-2025 | ||
| Epizyme | 12-Aug-2022 | ||
| Biohaven | 20-Jun-2019 | ||
| Nektar Therapeutics | 23-Jan-2014 | Public Investment 2nd Offering |
Royalty Pharma Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Royalty Pharma Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RPI 2019 Intermediate Finance Trust | New York, NY | 2019 | |
| RPI Intermediate Finance Trust | New York, NY | 2019 | |
| Orkambi | Boston, MA |
Royalty Pharma FAQs
-
What is Royalty Pharma?
Founded in 1996, Royalty Pharma is an asset manager based in New York.
-
When was Royalty Pharma founded?
Royalty Pharma was founded in 1996.
-
Where is Royalty Pharma headquartered?
Royalty Pharma is headquartered in New York, NY.
-
What is Royalty Pharma's total asset value?
Royalty Pharma has around in total assets under management.
-
How many investments has Royalty Pharma made?
Royalty Pharma has made 54 investments.
-
What has Royalty Pharma invested in?
Royalty Pharma has made numerous investments in companies like Cliramitug, PTC Therapeutics (Certain Royalty Rights), and Royalty Pharma (Cancer Drug Royalties in United States) within the Buildings and Property industry.
-
What has Royalty Pharma invested in recently?
Royalty Pharma's latest investment was on 22-Jul-2026 in Cliramitug, a company within the Buildings and Property industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
